Post by VVMF

VVMF - Viral Vector Manufacturing Facility will be at the Alliance for Regenerative Medicine’s 2026 𝗖𝗲𝗹𝗹 & 𝗚𝗲𝗻𝗲 𝗠𝗲𝗲𝘁𝗶𝗻𝗴 𝗼𝗻 𝘁𝗵𝗲 𝗠𝗲𝗱, taking place in Rome, 𝟮𝟴 -𝟯𝟬 𝗔𝗽𝗿𝗶𝗹. Join Anita van der Meer, Head of Business Development and Partnerships, to discuss partnering with VVMF and how we support the design, development, and clinical-grade manufacturing of 𝗟𝗩 𝗮𝗻𝗱 𝗔𝗔𝗩 𝘃𝗲𝗰𝘁𝗼𝗿𝘀, including: ✔️ Advanced process and analytical development ✔️ End-to-end viral vector manufacturing ✔️ Wrap‑around services and strategic advice to help you leverage Australia’s thriving biotech ecosystem 💡Did you know? Eligible companies can benefit from 𝗔𝘂𝘀𝘁𝗿𝗮𝗹𝗶𝗮’𝘀 𝗥&𝗗 𝗧𝗮𝘅 𝗜𝗻𝗰𝗲𝗻𝘁𝗶𝘃𝗲, offering a 𝗿𝗲𝗯𝗮𝘁𝗲 𝗼𝗳 𝘂𝗽 𝘁𝗼 𝟰𝟯.𝟱% - a powerful boost for biotech innovation. 📅 Schedule a meeting with Anita via the partnering platform 📧 Or contact us at [email protected] We look forward to connecting in Rome. #CGMed26 #CellandGeneTherapy #CellTherapy #GeneTherapy #VVMF #UnlockingtheFutureofMedicine #viralvectors #CDMO #AustraliaAdvantage Australian Trade and Investment Commission (Austrade) Investment NSW AusBiotech Ann Damien Steven Spezza Hanh Hoang Shaun M. Hayley van der Meer